Nashville Soccer Club Unveils New Man in Black Kit Honoring the Life & Legacy of Johnny Cash
17.2.2023 15:00:00 EET | Business Wire | Press release
Nashville Soccer Club unveiled today their brand-new Man in Black Kit, honoring one of the most influential singer-songwriters of all time, Johnny Cash. Watch the launch video here.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230217005049/en/
Photo ID (left to right): John Carter Cash & Hany Mukhtar Photo: Courtesy of Nashville SC
Created in collaboration with the estate of Johnny Cash, Sandbox Succession, and Wasserman Music, the Man in Black Kit was inspired by The Backline Supporters Collective, the club’s fans. On Feb. 29, 2020, Nashville SC inaugurated its journey in Major League Soccer in front of 59,069 fans, a state record for a soccer match. Prior to kickoff, The Backline unveiled their first ever MLS TIFO, featuring the Man in Black alongside the Nashville SC logo. Inspired by that moment, Nashville SC and The estate of Johnny Cash began collaborating to tell the story of the life and legacy of Cash.
The all-black ensemble is embellished by dark graphite and iron metallic accents including a jocktag of Johnny Cash’s iconic photo at Folsom Prison, Cash’s autograph on the back-of-the-neck, the Nashville SC crest, and an iron metallic Renasant Bank logo as well as an adidas logo. The left sleeve celebrates the Apple and MLS partnership by featuring the Apple TV and MLS logos, and the right sleeve features the Hyundai logo.
“From the first day we started Nashville Soccer Club, we talked a lot about being ‘uniquely Nashville,’” said Nashville SC CEO Ian Ayre. “This city is steeped in music history and Icons of that industry. None more so than the Man in Black himself, Johnny Cash. From our opening match on Feb. 29th, 2020 when our supporters, The Backline, unveiled a Tifo with that famous Johnny Cash image, there has clearly been a strong connection between both The Cash Family and the NSC family. I don’t think there can be a greater tribute to Johnny’s place in music history or Nashville than to have a team full of Men in Black take the field on behalf of Nashville SC.”
“Nashville meant so much to my father, both as a historical music community and a welcoming home,” says John Carter Cash . “Connecting the Cash legacy to Nashville Soccer Club and Major League Soccer, and the joy it’s bringing to Nashville residents, would have made him proud. I’m delighted to see the Man in Black celebrated alongside the Boys in Gold.”
Tomorrow, Saturday, Feb. 18, Nashville fans have the opportunity to see and purchase the Man in Black Kit at a public event at the Walk of Fame Park (across from the Country Music Hall of Fame). The festival-like celebration will kick-off at 11:30 a.m. CT with a DJ, player appearances, photo ops and much more. Other activations include a hospitality area and Heineken® Silver Beer Garden where fans can purchase $4 Heineken® products as well as get a first taste of the new Heineken® Silver, Nashville SC player autograph tent, a stage photo opportunity, Fanatics servicing and order pickup, and Tempo the Coyote’s Band Kids Club registration, among others.
Nashville SC will don the Man in Black Kit for the very first time on Saturday, Feb. 25 as it hosts New York City FC as the first match of the MLS Is Back weekend. Scheduled to kick off at 3:30 p.m. CT, the match will honor the collaboration with a special ‘Man In Black’ match. Limited tickets remain available at www.NashvilleSC.com/Tickets.
Fans around the world can witness the kit debut for free on MLS Season Pass, the new, unprecedented streaming service available on the Apple TV app that will feature every MLS match live, with no blackouts. The match will also broadcast on FOX and Fox Deportes.
To celebrate the launch of the Nashville SC Man in Black Kit, now featured on the official Nashville SC Apple Music playlist, fans can enjoy an exclusive pair of Johnny Cash singles: “God’s Gonna Cut You Down,” a rendition performed by breakout country artist Bailey Zimmerman; and a take on the classic “Man in Black” by Música Mexicana singer Carín León. Additionally, Nashville SC has created a dedicated Apple Maps Guide to everything fans need to know about Nashville SC Match Day, from prematch tailgates to in-stadium eats.
Following its debut, the Man in Black Kit will be featured throughout the 2023 and 2024 MLS seasons, and is available for fans to purchase here. In addition to the kit, the partnership will include special collaborations, which will be offered exclusively through Fanatics, the clubs official retail partner, throughout the two seasons.
MEDIA RESOURCES: Photos, video and b-roll
http://www.nashvillesc.com/maninblack
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230217005049/en/
Contact information
Zach Hunt
615-321-3110
zach@tsgnashville.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom